United States securities and exchange commission logo





                              July 22, 2022

       Kevin Chen
       Chief Executive Officer
       Edoc Acquisition Corp.
       7612 Main Street Fisher, Suite 200
       Victor, NY 14564

                                                        Re: Edoc Acquisition
Corp.
                                                            Preliminary Proxy
Statement on Schedule 14A
                                                            Filed July 15, 2022
                                                            File No. 001-39689

       Dear Mr. Chen:

              We have reviewed your filing and have the following comments. In
some of our
       comments, we may ask you to provide us with information so we may better
understand your
       disclosure.

              Please respond to these comments within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comments apply to your facts and circumstances, please tell us why in
your response.

                                                        After reviewing your
response to these comments, we may have additional comments.

       Preliminary Proxy Statement on Schedule 14A filed July 15, 2022

       General

   1.                                                   With a view toward
disclosure, please tell us whether your sponsor is, is controlled by, or
                                                        has substantial ties
with a non-U.S. person. If so, also include risk factor disclosure that
                                                        addresses how this fact
could impact your ability to complete your initial business
                                                        combination. For
instance, discuss the risk to investors that you may not be able to
                                                        complete an initial
business combination with a U.S. target company should the
                                                        transaction be subject
to review by a U.S. government entity, such as the Committee on
                                                        Foreign Investment in
the United States (CFIUS), or ultimately prohibited. Disclose that
                                                        as a result, the pool
of potential targets with which you could complete an initial business
                                                        combination may be
limited. Further, disclose that the time necessary for government
                                                        review of the
transaction or a decision to prohibit the transaction could prevent you from
                                                        completing an initial
business combination and require you to liquidate. Disclose the
                                                        consequences of
liquidation to investors, such as the losses of the investment opportunity
 Kevin Chen
Edoc Acquisition Corp.
July 22, 2022
Page 2
      in a target company, any price appreciation in the combined company, and
the warrants,
      which would expire worthless.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

      You may contact Daniel Crawford at 202-551-7767 or Suzanne Hayes at
202-551-
3675 with any questions.



                                                          Sincerely,
FirstName LastNameKevin Chen
                                                          Division of
Corporation Finance
Comapany NameEdoc Acquisition Corp.
                                                          Office of Life
Sciences
July 22, 2022 Page 2
cc:       Jessica Yuan
FirstName LastName